Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer
Clinical trial NCT04756765 · WITHDRAWN
Trial details
- NCT number
- NCT04756765
- Sponsor
- Stanford University
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2024-12-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.